DFS
56
-4
GPC
29
7
AAP
30
3
WHR
64
3
URBN
55
12
JWN
52
2
COP
54
4
DTE
47
2
TJX
42
-9
MPC
28
2
GRMN
68
-2
LLY
37
-2
JPM
57
-5
DNB
66
2
CFG
52
-2
MMM
28
-2
AMGN
47
8
TRV
46
-3
EMC
62
6
AAL
48
6
DFS
56
-4
GPC
29
7
AAP
30
3
WHR
64
3
URBN
55
12
JWN
52
2
COP
54
4
DTE
47
2
TJX
42
-9
MPC
28
2
GRMN
68
-2
LLY
37
-2
JPM
57
-5
DNB
66
2
CFG
52
-2
MMM
28
-2
AMGN
47
8
TRV
46
-3
EMC
62
6
AAL
48
6
Financhill
Back

Neurogene Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
75

NGNE
Neurogene

Last Price:
65.96
Seasonality Move:
58.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 60.7% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 60.7% based on the past 10 years of stock performance.

Neurogene Stock Rating

Buy
75
Neurogene (NGNE) is a Buy

Is Neurogene overpriced?

  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
73.59
52-Week Low:
12.49

Prediction Charts

Market Cap:
857.58M
Price in USD:
66.00
Volume:
960.71K
Beta:
-1.26

Technical Analysis

SMA50:
43.32
SMA100:
40.68
SMA200:
37.93
52-Wk Change:
382.46%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 66.00 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-15 49.85 50.05 50.75 47.49
Oct-16 50.53 53.26 54.38 50.53
Oct-18 53.21 54.40 55.21 53.11
Oct-21 54.64 52.66 54.64 52.30
Oct-22 52.59 49.97 52.68 48.00
Oct-23 49.97 48.55 51.42 48.15
Oct-24 48.69 48.20 49.38 47.67
Oct-25 48.45 48.37 50.85 47.76
Oct-28 49.14 45.93 51.19 45.80
Oct-29 45.40 45.27 46.94 44.49
Oct-30 45.08 43.58 46.01 43.58
Oct-31 43.56 44.01 44.31 42.23
Nov-1 44.73 46.07 46.23 44.47
Nov-4 56.17 66.00 73.59 55.00

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.